Ether

Ether

SCHEMBL9496506

CCOCC.FB(F)F.[Al+3].[H-].[H-].[H-].[H-].[Li+]

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Ether. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL4526542 0.90 ALDH1A1 (0.33) ALDH1A1
Ether SCHEMBL9009598 0.89 ALDH1A1 (0.37) ALDH1A1
Ether SCHEMBL40006 0.89
Ether SCHEMBL6535103 0.89 ALDH1A1 (0.37) ALDH1A1
Ether SCHEMBL28855718 0.89 ALDH1A1 (0.37) ALDH1A1
Ether SCHEMBL23704984 0.86 ALDH1A1 (0.35) ALDH1A1
Ether SCHEMBL16446730 0.86 ALDH1A1 (0.35) ALDH1A1
Ether SCHEMBL7988554 0.86
Ether SCHEMBL4526541 0.83 ALDH1A1 (0.33) ALDH1A1
Ether SCHEMBL4725961 0.83 ALDH1A1 (0.33) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5208223-A Enzyme inhibitors AMERICAN CYANAMID COMPANY (US) 1993-05-04 US disclosed
US-5144045-A Treatment of inflammatory related disorders AMERICAN CYANAMID COMPANY (US) 1992-09-01 US disclosed